Loading...
XIDX
SRAJ
Market cap7.96bUSD
Nov 12, Last price  
11,750.00IDR
Name

Sejahteraraya Anugrahjaya Tbk PT

Chart & Performance

D1W1MN
XIDX:SRAJ chart
P/E
—
P/S
55.54
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.33%
Rev. gr., 5y
15.06%
Revenues
2.59t
-17.75%
149,177,640,303167,481,196,178194,501,975,833221,473,537,146340,517,477,381449,070,584,340576,181,935,845631,679,891,159806,031,479,5701,002,002,454,0001,283,798,609,0001,924,453,141,0001,934,163,681,0002,503,174,000,0003,148,345,000,0002,589,440,000,000
Net income
-199.00b
L+746.34%
6,005,084,8874,705,078,3264,737,470,881-55,121,285,990-100,361,508,614-132,172,386,621-97,222,036,255-100,850,146,236-95,418,538,172-75,774,124,000-14,380,627,000165,308,239,000-44,187,231,000-38,490,000,000-23,513,000,000-199,000,000,000
CFO
129.67b
-52.54%
31,097,189,80046,919,447,07028,368,571,0967,915,136,62916,209,616,55216,014,793,94316,141,357,32215,235,285,14316,239,859,91575,416,192,00093,881,891,000336,786,663,000210,475,000,00055,917,000,000273,245,000,000129,670,000,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

PT Sejahteraraya Anugrahjaya Tbk is an Indonesian enterprise dedicated to providing medical care. Its business model is structured around two core divisions: inpatient treatment alongside its ancillary services, and outpatient consultations complete with their related infrastructure. The organization oversees a network of medical facilities operating under the Mayapada Hospital brand. Initially incorporated as PT Sejahtera Raya Anugrah in 1991, the entity formally adopted its present designation, PT Sejahteraraya Anugrahjaya Tbk, in December 1992. This Indonesian firm maintains its principal office in Tangerang and functions as a controlled entity within the PT Surya Cipta Inti Cemerlang group.
URL
https://mayapadahospital.com/
IPO date
Apr 11, 2011
Employees
Domiciled in
ID
Incorporated in
ID

Valuation

Title
IDR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT